Biorce
5 known investors
Find your way into Biorce
131 people in our graph share verified history with the Biorce team — schools, employers, funds. One of them is your warm intro.
Edward Yangunlockedknows Pedro Coelho · together at International Baccalaureate (overlapped)
×11knows the team · via International Baccalaureate
Aika is an operating system that uses AI and automation to orchestrate clinical trial development end-to-end, helping organizations accelerate protocol creation, prevent amendments, and interpret complex datasets across all stages of trial development.
Founders & leadership
PC
Pedro CoelhoinFounder / CEOPedro Coelho worked as a strategy consultant advising pharmaceutical and biotech companies on clinical research operations before founding Biorce in 2024, an AI platform designed to streamline clinical trial development.
Investors · 5
Endeavor CatalystNew York · $5.5M – $200M
MSMLisbon
YZR CapitalMunich
Norrsken VCreported · 2 sourcesStockholm · $1.1M – $3.2M
Also in the syndicate · 1
DST Global Partnerslead
Funding
SEC filings, press & company announcements$52.5M disclosed across 1 of 3 rounds · 2025–2026
- $52.5MSeries AFeb 2026 · 3 sourcesSource ↗
Source: company announcements and press reports — follow each round's link for the claim.
In the news
Frequently asked questions
- What does Biorce do?
- Aika is an operating system that uses AI and automation to orchestrate clinical trial development end-to-end, helping organizations accelerate protocol creation, prevent amendments, and interpret complex datasets across all stages of trial development.
- Who founded Biorce?
- Biorce was founded by Pedro Coelho.
- Who are Biorce's investors?
- Biorce's investors include Endeavor Catalyst, MSM, YZR Capital, Norrsken VC.
- How much funding has Biorce raised?
- Biorce has disclosed $52.5M raised across 1 of its 3 known rounds.